Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Tse, William T  [Clear All Filters]
2023
Galat Y, Du Y, Perepitchka M, Li X-N, Balyasnikova IV, Tse WT, Dambaeva S, Schneiderman S, Iannaccone PM, Becher O, et al. In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies. Oncoimmunology. 2023;12(1):2240670.
2021
Rossoff J, Jacobsohn D, Kwon S, Kletzel M, Duerst RE, Tse WT, Schneiderman J, Chaudhury S. Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies. Pediatr Blood Cancer. 2021:e29087.
2018
Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, J Rizzo D, Anderlini P, Leitman SF, Varni JW, Kobusingye H, et al. The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe). Biol Blood Marrow Transplant. 2018.
Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, J Rizzo D, Anderlini P, Leitman SF, Varni JW, Kobusingye H, et al. Higher risks of toxicity and incomplete recovery in 13-17 year old females after marrow donation: RDSafe peds results. Biol Blood Marrow Transplant. 2018.
2015
Khanolkar A, Wilks JD, Jennings LJ, Davies JL, Zollett JA, Lott LL, Fullmer ER, Bensen NE, Carlson-Leuer KM, Tse WT, et al. Signaling impairments in maternal T cells engrafted in an infant with a novel IL-2 receptor γ mutation. J Allergy Clin Immunol. 2015;135(4):1093-1096.e8.